内射人妻无码色AV天堂,BAOYU最新无码网站在线观看,亚洲AV无码一区二区三区网站,欧洲女人牲交视频免费
<option id="31iru"><tbody id="31iru"><i id="31iru"></i></tbody></option>
<sub id="31iru"></sub>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2023.12.29
DISSEMINATION OF CORPORATE COMMUNICATIONS
2023.12.18
VOLUNTARY ANNOUNCEMENT PROPOSED OFFERING AND LISTING OF SHARES OF HIGHTIDE THERA...
2023.12.18
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
2023.12.18
PROXY FORM
2023.12.18
NOTIFICATION LETTER
2023.12.18
Circular PROPOSED AMENDMENTS TO THE ARTICLES AND RELATED RULES OF PROCEDURES OF...
2023.12.18
ANNOUNCEMENT PROPOSED AMENDMENTS TO THE ARTICLES
2023.11.23
PROXY FORM FOR THE H SHAREHOLDERS’ CLASS MEETING
2023.11.23
PROXY FORM FOR EXTRAORDINARY GENERAL MEETING
2023.11.23
NOTIFICATION LETTER
第一頁
上一頁
3
4
5
6
7
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
